Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Websites for learning financial planning basics can provide a solid foundation. Explore resources to start your journey in personal finance.
18,400 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
Bitwise’s Q2 2026 review shows a third straight down quarter for its Large Cap Crypto Index, yet on-chain activity an...
Costco’s membership model has proven to be a durable moat. This analysis lays out why costco could poised major gains...
Income-focused investors face a tricky mood: chase reliable payouts or risk capital. Learn about three high-yield div...
Oil rises and stock indexes slip as tensions in the Strait of Hormuz intensify. Investors watch the ships dark clock ...
XRP remains around the $1 mark as the CLARITY Act stalls in the Senate, raising questions about regulatory clarity an...
Figma’s shares surged 11.9% in trading today, but without a flashy headline to explain the move. The action hints at ...
A cooler June CPI prints suggest inflation is cooling, potentially giving the Fed room to hold rates steady. Markets ...
Broadcom faced a sharp intraday drop that contrasted with a broader Nasdaq rally, highlighting a rotation in tech lea...
Investors weighing Dow and LYB face a crossroads in 2026. This guide breaks down business models, catalysts, risks, a...